Fujifilm Diosynth Biotechnologies Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
4,800
- Latest Deal Type
-
Grant
- Financing Rounds
-
4
- Investments
-
3
Fujifilm Diosynth Biotechnologies General Information
Description
Manufacturer of pharmaceutical products based in College Station, Texas. The company offers advanced therapies, cell therapy, gene therapy, analytic services, cell line development, vaccines, insect cell culture and formulation development, thereby helping clients to accelerate their progress, expand capabilities, streamline processes and strengthen innovation.
Contact Information
Website
www.fujifilmdiosynth.com(Operating Subsidiary)
Corporate Office
- 3939 Fujifilm Way
- College Station, TX 77845
- United States
Corporate Office
- 3939 Fujifilm Way
- College Station, TX 77845
- United States
Fujifilm Diosynth Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fujifilm Diosynth Biotechnologies Comparisons
Industry
Financing
Details
Fujifilm Diosynth Biotechnologies Competitors (30)
One of Fujifilm Diosynth Biotechnologies’s 30 competitors is Creative Biolabs, a Corporation company based in Shirley, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Creative Biolabs | Corporation | Shirley, NY | ||||
| Batavia Biosciences | Corporate Backed or Acquired | Leiden, Netherlands | ||||
| Parexel International | Private Equity-Backed | Raleigh, NC | ||||
| Vetter Pharma | Private Debt Financed | Ravensburg, Germany | ||||
| Lonza Group | Corporation | Basel, Switzerland |
Fujifilm Diosynth Biotechnologies Patents
Fujifilm Diosynth Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202505118-D0 | Control methods for interlinked bioprocessing rigs | Pending | 04-Apr-2025 | ||
| WO-2026210159-A1 | Control methods for interlinked bioprocessing rigs | Pending | 04-Apr-2025 | ||
| GB-202505116-D0 | Interlinked bio processing rigs | Pending | 04-Apr-2025 | ||
| WO-2026210158-A1 | Interlinked bioprocessing rigs | Pending | 04-Apr-2025 | ||
| US-20260226411-A1 | Methods for the production of dendritic cells by modulating retinoid signaling | Pending | 05-Feb-2025 | C12N5/0639 |
Fujifilm Diosynth Biotechnologies Signals
Fujifilm Diosynth Biotechnologies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fujifilm Diosynth Biotechnologies Investments & Acquisitions (3)
Fujifilm Diosynth Biotechnologies’s most recent deal was a Corporate Asset Purchase with Atara Biotherapeutics (T-Cell Operations and Manufacturing Facility in Thousand Oaks, California) for . The deal was made on 04-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Atara Biotherapeutics (T-Cell Operations and Manufacturing Facility in Thousand Oaks, California) | 04-Apr-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Biogen (Denmark Manufacturing Facility) | 01-Aug-2019 | Merger/Acquisition | Pharmaceuticals | ||
| TeraMedica | 13-May-2015 | Merger/Acquisition | Other Healthcare Technology Systems |
Fujifilm Diosynth Biotechnologies FAQs
-
When was Fujifilm Diosynth Biotechnologies founded?
Fujifilm Diosynth Biotechnologies was founded in 1994.
-
Where is Fujifilm Diosynth Biotechnologies headquartered?
Fujifilm Diosynth Biotechnologies is headquartered in College Station, TX.
-
What is the size of Fujifilm Diosynth Biotechnologies?
Fujifilm Diosynth Biotechnologies has 4,800 total employees.
-
What industry is Fujifilm Diosynth Biotechnologies in?
Fujifilm Diosynth Biotechnologies’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Fujifilm Diosynth Biotechnologies a private or public company?
Fujifilm Diosynth Biotechnologies is a Private company.
-
What is Fujifilm Diosynth Biotechnologies’s current revenue?
The current revenue for Fujifilm Diosynth Biotechnologies is .
-
Who are Fujifilm Diosynth Biotechnologies’s investors?
Merck & Co. has invested in Fujifilm Diosynth Biotechnologies.
-
Who are Fujifilm Diosynth Biotechnologies’s competitors?
Creative Biolabs, Batavia Biosciences, Parexel International, Vetter Pharma, and Lonza Group are some of the 30 competitors of Fujifilm Diosynth Biotechnologies.
-
When was Fujifilm Diosynth Biotechnologies acquired?
Fujifilm Diosynth Biotechnologies was acquired on 01-Jun-2021.
-
Who acquired Fujifilm Diosynth Biotechnologies?
Fujifilm Diosynth Biotechnologies was acquired by FujiFilm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process